compounded semaglutide fda enforcement news today Feds warn telehealth companies about "illegal marketing" of GLP-1s The FDA has received reports

Different Pattern of Volume Loss GLP-1-induced changes may affect facial fat compartments differently than natural aging or traditional weight loss, requiring specifically targeted treatment approaches

Another med spa in Ohio was given a summary suspension letter after investigators found unapproved dangerous injectable drugs, including CJC/Ipamorelin, Semax/Selank, and a vial labeled Kisspeptin that was prescribed by the facility's responsible person for herself

This Vitamin B-12 can be taken as a dietary supplement along with the foods to treat the deficiency

Primary human prostate cancer expresses GLP-1 receptors in in vitro conditions

Studies have shown that the peptide increases the expression of myogenic control factors such as MyoD and myogenin, which are key for muscle cell differentiation